← Back to Search

Behavioural Intervention

F3 Group for Depression

N/A
Waitlist Available
Led By Nicholas T Trapp, M.D.
Research Sponsored by Nicholas Trapp
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of major depressive disorder
Age between 18 and 90 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-assessment will be obtained within approximately 1 week of starting rtms. post-assessment will be obtained immediately following completion of rtms course, usually 4-6 weeks later.
Awards & highlights

Study Summary

This trial will test if different locations for administering rTMS treatment will have different effects for people with major depressive disorder.

Eligible Conditions
  • Depression

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-assessment will be obtained within approximately 1 week of starting rtms. post-assessment will be obtained immediately following completion of rtms course, usually 4-6 weeks later.
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-assessment will be obtained within approximately 1 week of starting rtms. post-assessment will be obtained immediately following completion of rtms course, usually 4-6 weeks later. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Clinical Global Impression Scale
Cognitive measures
Emotion measures
+8 more

Trial Design

2Treatment groups
Active Control
Group I: F3 GroupActive Control1 Intervention
rTMS will be targeted at the left prefrontal scalp target identified as F3 according to the 10-20 EEG system.
Group II: 5.5cm Rule GroupActive Control1 Intervention
rTMS will be targeted at a left prefrontal target 5.5cm anterior to the primary motor strip identified on the scalp during motor threshold testing.

Find a Location

Who is running the clinical trial?

Nicholas TrappLead Sponsor
Nicholas T Trapp, M.D.Principal InvestigatorUniversity of Iowa

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~18 spots leftby Mar 2025